The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
IU School of Medicine
With more than 60 academic departments and specialty divisions across nine campuses and strong clinical partnerships with Indiana’s most advanced hospitals and physician networks, Indiana University School of Medicine is continuously advancing its miss...
D. Wade Clapp, MD, chair of the Department of Pediatrics at Indiana University School of Medicine, has been elected to the National Academy of Medicine (NAM). The group announced the election of 100 new members during its annual meeting on Monday, October 19, 2020. Election to the academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
The Walther Cancer Foundation will invest $11 million to advance collaborative cancer research at Indiana University and Purdue University by supporting scientists through bioinformatics — an increasingly critical aspect of their work.
Indiana University School of Medicine has announced the hiring of a world-recognized medical oncologist and multiple myeloma researcher to lead the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, bolstered by a $15 million fund established by the Walther Cancer Foundation to support him in this role.
Indiana University School of Medicine researchers are participating in the Rare and Atypical Diabetes Network (RADIANT), a nationwide study funded by the National Institutes of Health. The study seeks to discover new forms of diabetes, identify their causes, and understand how they differ from more common types of diabetes.
Indiana University School of Medicine has named Laurie Gutmann, MD, the new chair for the Department of Neurology. Gutmann also will serve as co-director of the Neuroscience Institute, an umbrella entity designed to facilitate collaboration among neuroscience disciplines at IU School of Medicine and IU Health.
Mark R. Kelley, PhD, is the newest member of the IU Ventures Investment Committee. Kelley, a professor of pediatrics and cancer researcher at Indiana University School of Medicine, was appointed by Jay L. Hess, MD, PhD, MHSA, dean of IU School of Medicine and IU Ventures board member. Kelley succeeds Distinguished Professor Emeritus Mervin Yoder, MD, who served on the committee from 2014 to 2020.
Supported by a $1.3 million grant from the U.S. Administration for Community Living, Department of Health and Human Services, Indiana University School of Medicine and its partners have launched a 36-month venture to enhance, strengthen and expand supports for people with Alzheimer’s Disease and Related Dementias and their caregivers in 34 Indiana counties.
Indiana University School of Medicine is promoting one of its own to serve as the next leader of the Department of Emergency Medicine. Peter S. Pang, MD, MS, will assume the role of department chair, effective October 1, and will have oversight and responsibility for the program’s clinical, education and research programs. He has served as interim chair since October 2019.
As researchers around the world work feverishly to discover a vaccine in the battle to prevent COVID-19, Indiana University School of Medicine has been selected as a site for a vaccine trial. Biopharmaceutical company AstraZeneca, in partnership with Oxford University, is moving forward with its late-stage clinical trial for a vaccine known as AZD1222.
In honor of Indiana University’s bicentennial, IU School of Medicine is awarding 11 highly accomplished students with four-year scholarships and inclusion in a leadership development program involving the school’s top executives and esteemed faculty.